D09.20
Carcinoma in situ of unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ of the eye, classified under ICD-10 code D09.20, is a type of early-stage cancer where abnormal cells are found in the surface layer of the eye. Being a 'carcinoma in situ' means that the cancerous cells have not yet invaded deeper tissues or spread to other parts of the body. It is considered a precancerous condition that requires monitoring and, in some cases, treatment to prevent progression to invasive cancer. This condition can affect various parts of the eye, including the conjunctiva or cornea, and it is essential for affected individuals to have regular eye examinations for early detection and management.
Causes & Symptoms
Clinical Causes: Chronic ultraviolet (UV) light exposure, especially for individuals with outdoor occupations Prolonged exposure to environmental carcinogens History of tanning or tanning bed use Immunosuppression due to medical conditions or treatments Genetic predisposition and family history of eye cancers Previous ocular surface injuries or inflammatory conditions
Key Symptoms: Persistent redness or irritation of the eye A noticeable growth or lesion on the surface of the eye Changes in the appearance of the eye's surface, such as a white or yellowish plaque Blurry vision or visual disturbances Discomfort or a sensation of a foreign body in the eye In some cases, the condition may be asymptomatic and found during routine eye exams
Diagnostic & Treatment
Diagnosis Path: Visual inspection of the eye and mobility assessments Use of slit-lamp biomicroscopy to examine the eye's surface in detail Photographic documentation of lesions Biopsy of suspicious areas to confirm the presence of carcinoma cells Additional imaging tests, such as ultrasound or confocal microscopy, may be utilized to assess the lesion's extent
Treatment Protocols: Surgical excision of the lesion with adequate margins to ensure complete removal Cryotherapy, which involves freezing abnormal cells to destroy them Topical chemotherapeutic agents, such as 5-fluorouracil or mitomycin C, applied directly to the affected area Ocular surface vaporization techniques, like laser therapy, to ablate abnormal tissue Regular follow-up appointments to monitor for recurrence or progression
Clinical Advice & FAQs
Billing Guidance
Is D09.20 a billable ICD-10 code?
Yes, D09.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D09.20?
Clinical documentation must specify the nature of Carcinoma in situ of unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference